Jane Street Group, LLC Emergent Bio Solutions Inc. Transaction History

Jane Street Group, LLC

  • $445 Billion
  • Q3 2024

A detailed history of Jane Street Group, LLC transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 147,320 shares of EBS stock, worth $1.31 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
147,320
Previous 490,750 69.98%
Holding current value
$1.31 Million
Previous $3.35 Million 63.24%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$5.72 - $14.77 $1.96 Million - $5.07 Million
-343,430 Reduced 69.98%
147,320 $1.23 Million
Q2 2024

Aug 14, 2024
BUY
$1.86 - $6.98 $683,687 - $2.57 Million
367,574 Added 298.41%
490,750 $3.35 Million
Q1 2024

May 15, 2024
SELL
$1.5 - $3.41 $185,761 - $422,297
-123,841 Reduced 50.13%
123,176 $311,000
Q4 2023

Feb 14, 2024
SELL
$1.82 - $3.16 $716,006 - $1.24 Million
-393,410 Reduced 61.43%
247,017 $592,000
Q3 2023

Nov 14, 2023
BUY
$3.17 - $7.91 $1.67 Million - $4.17 Million
527,061 Added 464.92%
640,427 $2.18 Million
Q2 2023

Aug 14, 2023
BUY
$7.35 - $13.21 $594,409 - $1.07 Million
80,872 Added 248.88%
113,366 $833,000
Q1 2023

May 15, 2023
BUY
$7.79 - $16.29 $253,128 - $529,327
32,494 New
32,494 $336,000
Q3 2022

Nov 14, 2022
BUY
$20.09 - $35.8 $678,901 - $1.21 Million
33,793 New
33,793 $709,000
Q3 2022

Nov 14, 2022
BUY
$20.09 - $35.8 $678,901 - $1.21 Million
33,793 New
33,793 $709,000
Q2 2022

Aug 16, 2022
SELL
$27.42 - $43.63 $1.31 Million - $2.08 Million
-47,599 Closed
0 $0
Q1 2022

May 17, 2022
SELL
$36.48 - $52.22 $441,882 - $632,540
-12,113 Reduced 20.29%
47,599 $1.96 Million
Q4 2021

Feb 15, 2022
BUY
$33.11 - $55.01 $540,322 - $897,708
16,319 Added 37.61%
59,712 $2.6 Million
Q3 2021

Nov 16, 2021
BUY
$50.07 - $66.05 $678,248 - $894,713
13,546 Added 45.38%
43,393 $2.17 Million
Q2 2021

Aug 16, 2021
BUY
$56.61 - $80.46 $447,558 - $636,116
7,906 Added 36.03%
29,847 $1.88 Million
Q1 2021

May 18, 2021
SELL
$86.23 - $125.19 $1.88 Million - $2.73 Million
-21,767 Reduced 49.8%
21,941 $2.04 Million
Q4 2020

Feb 17, 2021
BUY
$79.17 - $111.47 $727,413 - $1.02 Million
9,188 Added 26.62%
43,708 $3.92 Million
Q3 2020

Nov 17, 2020
SELL
$81.91 - $134.94 $832,860 - $1.37 Million
-10,168 Reduced 22.75%
34,520 $3.57 Million
Q2 2020

Aug 17, 2020
BUY
$54.33 - $89.52 $2.13 Million - $3.51 Million
39,254 Added 722.38%
44,688 $3.53 Million
Q1 2020

May 15, 2020
BUY
$49.34 - $68.76 $21,314 - $29,704
432 Added 8.64%
5,434 $314,000
Q4 2019

Feb 14, 2020
SELL
$51.21 - $59.06 $42,606 - $49,137
-832 Reduced 14.26%
5,002 $270,000
Q3 2019

Nov 14, 2019
BUY
$40.6 - $57.2 $236,860 - $333,704
5,834 New
5,834 $305,000

Others Institutions Holding EBS

# of Institutions
160
Shares Held
33.8M
Call Options Held
453K
Put Options Held
931K
View Full List

About Emergent BioSolutions Inc.

EBS Quotes by TradingView
  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $442M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email